Chapter 24. Hepatitis B Virus

  1. Donald A. Molony MD3,4 and
  2. Jonathan C. Craig MD, PhD5,6
  1. M. Aamir Ali MD1,2,
  2. Scott D. Cohen MD1,2 and
  3. Paul L. Kimmel MD, FACP, FASN1,2

Published Online: 4 MAR 2009

DOI: 10.1002/9781444303391.ch24

Evidence-Based Nephrology

Evidence-Based Nephrology

How to Cite

Ali, M. A., Cohen, S. D. and Kimmel, P. L. (2008) Hepatitis B Virus, in Evidence-Based Nephrology (eds D. A. Molony and J. C. Craig), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444303391.ch24

Editor Information

  1. 3

    Division of Renal Disease and Hypertension, University of Texas, USA

  2. 4

    Houston Medical School, Houston, Texas, USA

  3. 5

    School of Public Health, University of Sydney, Australia

  4. 6

    Department of Nephrology, The Children's Hospital at Westmead, Sydney, Australia

Author Information

  1. 1

    Divisions of Nutritional and Gastrointestinal Disease and Renal Diseases and Hypertension, USA

  2. 2

    Department of Medicine, George, Washington University Medical Center, Washington D.C., USA

Publication History

  1. Published Online: 4 MAR 2009
  2. Published Print: 5 DEC 2008

ISBN Information

Print ISBN: 9781405139755

Online ISBN: 9781444303391



  • Hepatitis B virus (HBV);
  • HBV infection and renal disease;
  • HBV-associated membranous nephropathy;
  • HBV-associated MPGN;
  • Alpha interferon (IFN-α);
  • HBV and essential mixed cryoglobulinemia;
  • HBV and ESRD


This chapter contains sections titled:

  • Hepatitis B virus

  • HBV infection and renal disease

  • HBV-associated membranous nephropathy

  • HBV-associated MPGN

  • Treatment

  • HBV and PAN

  • HBV and essential mixed cryoglobulinemia

  • HBV and IgAN

  • HBV and FSGS

  • HBV and ESRD

  • Conclusions

  • References